Veterinary Medicines

Biocan Novel DHPPi, Lyophilisate and solvent for suspension for injection

Authorised
  • Canine distemper virus, strain CDV Bio 11/A, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
Download as PDF

Product identification

Medicine name:
Biocan Novel DHPPi, Lyophilisate and solvent for suspension for injection
Biocan Novel DHPPi liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai suņiem
Active substance:
  • Canine distemper virus, strain CDV Bio 11/A, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain CDV Bio 11/A, Live
    5.10
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
    5.30
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
    6.60
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
    5.10
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:
  • Glass Vial 50 x 1.0 Dose
  • Glass Vial 25 x 1.0 Dose
  • Glass Vial 10 x 1.0 Dose

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/14/0049
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0124/001
Concerned member states:
  • Bulgaria
  • Croatia
  • Cyprus
  • Estonia
  • Hungary
  • Latvia
  • Lithuania
  • Poland
  • Romania
  • Slovakia
  • Slovenia

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 8/01/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 8/01/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 8/01/2025
Download